Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals

Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals

Limited data are available on the diagnostic utility of circulating tumor DNA (ctDNA) in early-stage thyroid cancers for <i>BRAF</i>, <i>KRAS</i>, <i>NRAS</i>, and <i>TERT</i> promoter mutations, which are known detectable markers for thyroid cancers....

Full description

Bibliographic Details
Main Authors: Yong Joon Suh, Mi Jung Kwon, Hye-Mi Noh, Hong Kyu Lee, Yong Joon Ra, Nan Young Kim
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Healthcare
Subjects:
circulating tumor DNA
thyroid cancer
mutation
clinical diagnosis
Online Access:https://www.mdpi.com/2227-9032/9/4/386

Internet

https://www.mdpi.com/2227-9032/9/4/386

Similar Items